AP2006003735A0 - Indentification of self and non-self antigens implicated in autoimmune diseases - Google Patents
Indentification of self and non-self antigens implicated in autoimmune diseasesInfo
- Publication number
- AP2006003735A0 AP2006003735A0 AP2006003735A AP2006003735A AP2006003735A0 AP 2006003735 A0 AP2006003735 A0 AP 2006003735A0 AP 2006003735 A AP2006003735 A AP 2006003735A AP 2006003735 A AP2006003735 A AP 2006003735A AP 2006003735 A0 AP2006003735 A0 AP 2006003735A0
- Authority
- AP
- ARIPO
- Prior art keywords
- self
- indentification
- autoimmune diseases
- antigens implicated
- implicated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/799,005 US7084247B2 (en) | 2004-03-11 | 2004-03-11 | Identification of self and non-self antigens implicated in autoimmune diseases |
PCT/US2005/008326 WO2005087261A2 (en) | 2004-03-11 | 2005-03-10 | Identification of self and non-self antigens implicated in autoimmune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2006003735A0 true AP2006003735A0 (en) | 2006-10-31 |
Family
ID=34920407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2006003735A AP2006003735A0 (en) | 2004-03-11 | 2005-03-10 | Indentification of self and non-self antigens implicated in autoimmune diseases |
Country Status (17)
Country | Link |
---|---|
US (2) | US7084247B2 (xx) |
EP (1) | EP1732595A2 (xx) |
JP (1) | JP2007528422A (xx) |
KR (1) | KR20070026450A (xx) |
CN (1) | CN1942202A (xx) |
AP (1) | AP2006003735A0 (xx) |
AU (1) | AU2005221712A1 (xx) |
BR (1) | BRPI0508633A (xx) |
CA (1) | CA2559065A1 (xx) |
EA (1) | EA200601671A1 (xx) |
IL (1) | IL177961A0 (xx) |
MA (1) | MA28525B1 (xx) |
MX (1) | MXPA06010364A (xx) |
NO (1) | NO20064610L (xx) |
TN (1) | TNSN06273A1 (xx) |
WO (1) | WO2005087261A2 (xx) |
ZA (1) | ZA200607552B (xx) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7084247B2 (en) * | 2004-03-11 | 2006-08-01 | Peptimmune, Inc. | Identification of self and non-self antigens implicated in autoimmune diseases |
US20070093449A1 (en) * | 2005-10-14 | 2007-04-26 | De Porre Peter M R | Novel IV formulation of tipifarnib |
DE602007005349D1 (de) * | 2006-01-17 | 2010-04-29 | Organon Nv | SELEKTIVE ENZYMATISCHE HYDROLYSE VON C-TERMINALEN tert-BUTYL-PEPTIDESTERN |
US8378072B2 (en) * | 2006-04-13 | 2013-02-19 | Declion Pharmaceuticals, Inc. | Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability |
JP2009069050A (ja) * | 2007-09-14 | 2009-04-02 | Nec Corp | 化合物のカラム担体への固定化方法 |
WO2009051797A1 (en) * | 2007-10-16 | 2009-04-23 | Peptimmune, Inc. | Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
NZ589302A (en) * | 2008-04-17 | 2012-11-30 | Declion Pharmaceuticals Inc | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
ES2381849T3 (es) | 2008-11-17 | 2012-06-01 | Borealis Ag | Procedimiento multietapa para producir polietileno con formación de gel reducida |
CA2761907A1 (en) * | 2009-05-14 | 2010-11-18 | Oatmeal Biotechnologies Group, L.L.C. | Platform technologies for spontaneously occurring diseases |
GB201112806D0 (en) * | 2011-07-26 | 2011-09-07 | Bauer Johann | Use of epitopes inducing specific tolerance for the prevention of tissue rejection |
EP2570455A1 (en) | 2011-09-16 | 2013-03-20 | Borealis AG | Polyethylene composition with broad molecular weight distribution and improved homogeneity |
EP2599828A1 (en) | 2011-12-01 | 2013-06-05 | Borealis AG | Multimodal polyethylene composition for the production of pipes with improved slow crack growth resistance |
US11458199B2 (en) * | 2012-08-21 | 2022-10-04 | Opko Pharmaceuticals, Llc | Liposome formulations |
EP2730612B1 (en) | 2012-11-09 | 2016-09-14 | Abu Dhabi Polymers Company Limited (Borouge) | Polymer composition comprising a blend of a multimodal polyethylene and a further ethylene polymer suitable for the production of a drip irrigation pipe |
EP2730611B1 (en) | 2012-11-09 | 2017-01-04 | Abu Dhabi Polymers Company Limited (Borouge) | Drip irrigation pipe comprising a polymer composition comprising a multimodal polyethylene base resin |
EP2740761B1 (en) | 2012-12-05 | 2016-10-19 | Borealis AG | Polyethylene composition with improved balance of slow crack growth resistance, impact performance and pipe pressure resistance for pipe applications |
EP2860200B1 (en) | 2013-10-10 | 2017-08-02 | Borealis AG | Polyethylene composition for pipe and pipe coating applications |
EP2860204B1 (en) | 2013-10-10 | 2018-08-01 | Borealis AG | Polyethylene composition for pipe applications |
PL2860202T3 (pl) | 2013-10-10 | 2018-11-30 | Borealis Ag | Polietylen odporny na wysoką temperaturę i sposób jego wytwarzania |
EP2860201A1 (en) | 2013-10-10 | 2015-04-15 | Borealis AG | High temperature resistant polyethylene and process for the production thereof |
US10801070B2 (en) | 2013-11-25 | 2020-10-13 | The Broad Institute, Inc. | Compositions and methods for diagnosing, evaluating and treating cancer |
WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
US20160310584A1 (en) * | 2013-12-06 | 2016-10-27 | The Broad Institute Inc. | Formulations for neoplasia vaccines |
KR20160101073A (ko) | 2013-12-20 | 2016-08-24 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신생항원 백신과의 병용 요법 |
US10301370B2 (en) * | 2014-05-02 | 2019-05-28 | The Trustees Of The University Of Pennsylvania | Compositions and methods of chimeric autoantibody receptor T cells |
US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
US10993997B2 (en) | 2014-12-19 | 2021-05-04 | The Broad Institute, Inc. | Methods for profiling the t cell repertoire |
MY190974A (en) | 2015-05-20 | 2022-05-25 | Massachusetts Gen Hospital | Shared neoantigens |
WO2018140391A1 (en) | 2017-01-24 | 2018-08-02 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
KR102593922B1 (ko) | 2018-10-31 | 2023-10-25 | 보레알리스 아게 | 개선된 균질성을 갖는 고압력 저항성 파이프용 폴리에틸렌 조성물 |
EP3647645A1 (en) | 2018-10-31 | 2020-05-06 | Borealis AG | Polyethylene composition for high pressure resistant pipes |
AU2019388183B2 (en) | 2018-11-28 | 2022-03-24 | Abu Dhabi Polymers Co. Ltd (Borouge) L.L.C. | Polyethylene composition for film applications |
US20220282074A1 (en) | 2019-07-22 | 2022-09-08 | Abu Dhabi Polymers Co. Ltd (Borouge) L.L.C., | Single site catalysed multimodal polyethylene composition |
EP4019583B1 (en) | 2020-12-28 | 2024-04-10 | ABU DHABI POLYMERS CO. LTD (BOROUGE) - Sole Proprietorship L.L.C. | Polyethylene composition for film applications with improved toughness and stiffness |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4973577A (en) * | 1986-04-04 | 1990-11-27 | The Salk Institute For Biological Studies | FSH-releasing peptides |
US5260422A (en) | 1988-06-23 | 1993-11-09 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
US5194425A (en) * | 1988-06-23 | 1993-03-16 | Anergen, Inc. | Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
US5130297A (en) * | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
WO1990008161A1 (en) | 1989-01-12 | 1990-07-26 | The Blood Center Of Southeastern Wisconsin | Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses |
CA2106567A1 (en) | 1991-03-22 | 1992-09-23 | William V. Williams | Method of modulating mammalian t-cell response |
AU3178393A (en) | 1991-11-27 | 1993-06-28 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Nucleotide and amino acid sequence of pemphigus vulgaris antigen and methods of use |
US5719064A (en) | 1992-08-31 | 1998-02-17 | Oklahoma Medical Research Foundation | Peptide diagnostics and therapeutics for spondyloarthropathies |
AU4851893A (en) | 1992-09-11 | 1994-04-12 | Washington University | Peptides tolerizing t-cells and compositions thereof |
EP0726708A1 (en) | 1993-11-05 | 1996-08-21 | Pathogenesis Corporation | Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof |
US6329499B1 (en) * | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
US5874531A (en) * | 1995-03-07 | 1999-02-23 | President And Fellows Of Harvard College | Identification of self and non-self antigens implicated autoimmune disease |
AU767185B2 (en) * | 1998-03-23 | 2003-11-06 | President And Fellows Of Harvard College | Synthesis of compounds and libraries of compounds |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US7084247B2 (en) * | 2004-03-11 | 2006-08-01 | Peptimmune, Inc. | Identification of self and non-self antigens implicated in autoimmune diseases |
-
2004
- 2004-03-11 US US10/799,005 patent/US7084247B2/en not_active Expired - Fee Related
-
2005
- 2005-03-10 AU AU2005221712A patent/AU2005221712A1/en not_active Abandoned
- 2005-03-10 MX MXPA06010364A patent/MXPA06010364A/es not_active Application Discontinuation
- 2005-03-10 EA EA200601671A patent/EA200601671A1/ru unknown
- 2005-03-10 AP AP2006003735A patent/AP2006003735A0/xx unknown
- 2005-03-10 CA CA002559065A patent/CA2559065A1/en not_active Abandoned
- 2005-03-10 WO PCT/US2005/008326 patent/WO2005087261A2/en active Application Filing
- 2005-03-10 KR KR1020067021038A patent/KR20070026450A/ko not_active Application Discontinuation
- 2005-03-10 EP EP05751786A patent/EP1732595A2/en not_active Withdrawn
- 2005-03-10 JP JP2007503086A patent/JP2007528422A/ja active Pending
- 2005-03-10 BR BRPI0508633-7A patent/BRPI0508633A/pt not_active IP Right Cessation
- 2005-03-10 CN CNA2005800109681A patent/CN1942202A/zh active Pending
-
2006
- 2006-03-23 US US11/388,121 patent/US20060159672A1/en not_active Abandoned
- 2006-09-07 IL IL177961A patent/IL177961A0/en unknown
- 2006-09-08 ZA ZA200607552A patent/ZA200607552B/en unknown
- 2006-09-11 TN TNP2006000273A patent/TNSN06273A1/en unknown
- 2006-10-11 NO NO20064610A patent/NO20064610L/no not_active Application Discontinuation
- 2006-10-11 MA MA29378A patent/MA28525B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
KR20070026450A (ko) | 2007-03-08 |
AU2005221712A1 (en) | 2005-09-22 |
CN1942202A (zh) | 2007-04-04 |
BRPI0508633A (pt) | 2007-08-07 |
TNSN06273A1 (en) | 2007-12-03 |
US20060159672A1 (en) | 2006-07-20 |
ZA200607552B (en) | 2008-05-28 |
US7084247B2 (en) | 2006-08-01 |
JP2007528422A (ja) | 2007-10-11 |
WO2005087261A3 (en) | 2005-12-08 |
WO2005087261A2 (en) | 2005-09-22 |
MXPA06010364A (es) | 2007-03-07 |
US20050202034A1 (en) | 2005-09-15 |
MA28525B1 (fr) | 2007-04-03 |
EA200601671A1 (ru) | 2007-02-27 |
NO20064610L (no) | 2006-12-04 |
IL177961A0 (en) | 2006-12-31 |
CA2559065A1 (en) | 2005-09-22 |
EP1732595A2 (en) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2006003735A0 (en) | Indentification of self and non-self antigens implicated in autoimmune diseases | |
EP1827391A4 (en) | DOSAGE FORMS AND METHODS OF USE THEREOF | |
HK1099935A1 (en) | Anti-cd3 antibodies and methods of use thereof -cd3 | |
IL213843A0 (en) | 4-aminotetracyclines and methods of use thereof | |
IL179476A0 (en) | Antibodies against human interleukin-13 and uses therefor | |
TWI318767B (en) | 3t1d memory cells using gated diodes and methods of use thereof | |
EP1778210A4 (en) | CONJUGATES OF FATTY ACID AND AMINO ACIDS AND METHODS OF USE | |
ZA200607749B (en) | Preparation of canola protein isolate and use in aquaculture | |
EP1794589A4 (en) | PROTEIN ARRAYS AND METHOD OF USE THEREOF | |
IL199045A0 (en) | Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases | |
IL179140A0 (en) | Antibody drug conjuates and methods | |
IL177193A0 (en) | Anti-cd3 and antigen -specific immunotherapy to treat autoimmunity | |
IL180817A0 (en) | Specific inhibition of autoimmunity and diseases associated with autoantigens | |
HK1104563A1 (en) | Estrogen receptors and methods of use | |
EP1789047A4 (en) | PROCESS FOR TREATING DISEASES USING NALMEFENE AND ITS ANALOGUES | |
ZA200902419B (en) | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases | |
EP1789027A4 (en) | Therapeutic Use of Anti- TF Antigen Antibodies | |
EP1853632A4 (en) | MODIFICATION OF AMINES AND ALCOHOLS | |
EP1950565A4 (en) | METHOD FOR DETERMINING ANTIGEN AND KIT USABLE IN THE METHOD | |
EP1735281A4 (en) | SYNTHESIS OF INDENOISOQUINOLINIUMS AND TECHNIQUES OF USE | |
EP1740120A4 (en) | LONG-TERM FORMULATIONS OF NALTREXONE AND METHOD OF USE | |
EP1848806A4 (en) | ANTI-T CELL AND AUTOANTIGEN TREATMENT OF AN AUTOIMMUNE DISEASE | |
EP1776126A4 (en) | METHOD FOR THE USE OF REGENERATIVE CELLS IN THE TREATMENT OF STROKE AND RELATED DISEASES AND DISORDERS | |
HK1155670A1 (en) | Therapeutic use of anti-cs1 antibodies | |
IL177868A0 (en) | Anti-inflammatory peptides and methods of use thereof |